TickerFacts.

A business in context

CUE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-12 · 0002138368-26-000009

  2. 4 · Ownership change

    Report date 2026-10-12 · 0001725092-26-000019

  3. 4 · Ownership change

    Report date 2026-10-12 · 0001579629-26-000012

  4. 8-K · Current report

    Report date 2026-09-20 · 0001193125-26-396094 · Items 7.01,8.01,9.01

  5. 4/A · Ownership change

    Report date 2026-07-09 · 0002059447-26-000006

  6. 4/A · Ownership change

    Report date 2026-07-09 · 0001974756-26-000006

  7. 4 · Ownership change

    Report date 2026-08-13 · 0002138368-26-000007

  8. 4 · Ownership change

    Report date 2026-08-13 · 0001579629-26-000008

  9. 4 · Ownership change

    Report date 2026-08-12 · 0001725092-26-000013

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-352128

  11. 8-K · Current report

    Report date 2026-08-14 · 0001193125-26-352126 · Items 2.02

  12. 8-K · Current report

    Report date 2026-07-27 · 0001193125-26-330730 · Items 5.02

  13. 8-K · Current report

    Report date 2026-07-09 · 0001193125-26-301052 · Items 1.01,3.02,5.02,8.01,9.01

  14. 8-K · Current report

    Report date 2026-06-01 · 0001193125-26-255479 · Items 5.02,5.07,9.01

  15. 8-K · Current report

    Report date 2026-05-29 · 0001193125-26-253709 · Items 5.02,8.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-01 · 0001193125-26-233369

  17. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-224101 · Items 9.01

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-224091

  19. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-198588 · Items 1.01,3.02,5.02,8.01,9.01

  20. 8-K · Current report

    Report date 2026-04-22 · 0001193125-26-168907 · Items 3.03,5.03

  21. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152826 · Items 5.07

  22. 8-K · Current report

    Report date 2026-04-01 · 0001193125-26-144569 · Items 8.01

  23. 8-K · Current report

    Report date 2026-03-23 · 0001193125-26-128993 · Items 5.02

  24. DEF 14A · Proxy statement

    Report date 2026-03-16 · 0001193125-26-108301

  25. 8-K · Current report

    Report date 2026-03-16 · 0001193125-26-108292 · Items 2.02,9.01

  26. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-108287

  27. 8-K · Current report

    Report date 2026-02-18 · 0001193125-26-056983 · Items 8.01

  28. 8-K · Current report

    Report date 2026-02-09 · 0001193125-26-047717 · Items 5.02

  29. 8-K · Current report

    Report date 2025-12-19 · 0001193125-25-326925 · Items 1.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-11-24 · 0001193125-25-292093 · Items 7.01

  31. 8-K · Current report

    Report date 2025-11-17 · 0001193125-25-289713 · Items 5.02

  32. 8-K · Current report

    Report date 2025-11-12 · 0001193125-25-277468 · Items 2.02,9.01

  33. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-277466

  34. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-268135 · Items 1.01,7.01,9.01

  35. 8-K · Current report

    Report date 2025-09-26 · 0000950130-25-000140 · Items 5.02

  36. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107270

  37. 8-K · Current report

    Report date 2025-08-12 · 0000950170-25-107268 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-06-30 · 0000950170-25-092168 · Items 1.01

  39. 8-K · Current report

    Report date 2025-06-04 · 0000950170-25-084279 · Items 5.02,5.03,5.07,9.01

  40. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069125

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 18 transaction rows18AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

35 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-13
2026-08-17
Meluzio Michael VincentM · Exercise / conversion
Acquired
Common Stock13647.00.0
2026-08-13
2026-08-17
Meluzio Michael VincentS · Sale
Disposed
Common Stock3.031.13
2026-08-13
2026-08-17
Meluzio Michael VincentS · Sale
Disposed
Common Stock4106.030.35
2026-08-13
2026-08-17
Meluzio Michael VincentS · Sale
Disposed
Common Stock1519.029.37
2026-08-13
2026-08-17
Meluzio Michael VincentM · Exercise / conversion
Disposed
Common Stock
Derivative security
13647.00.0
2026-08-13
2026-08-14
Lin Shao-LeeS · Sale
Disposed
Common Stock5423.027.19
2026-08-13
2026-08-14
Lin Shao-LeeS · Sale
Disposed
Common Stock10460.029.48
2026-08-13
2026-08-14
Lin Shao-LeeS · Sale
Disposed
Common Stock2375.028.11
2026-08-13
2026-08-17
Ray SumitaS · Sale
Disposed
Common Stock2383.029.37
2026-08-13
2026-08-17
Ray SumitaM · Exercise / conversion
Acquired
Common Stock18196.00.0
2026-08-13
2026-08-17
Ray SumitaS · Sale
Disposed
Common Stock6442.030.35
2026-08-13
2026-08-17
Ray SumitaS · Sale
Disposed
Common Stock4.031.13
2026-08-13
2026-08-17
Ray SumitaM · Exercise / conversion
Disposed
Common Stock
Derivative security
18196.00.0
2026-08-12
2026-08-14
Lin Shao-LeeS · Sale
Disposed
Common Stock34225.026.99
2026-08-12
2026-08-14
Lin Shao-LeeM · Exercise / conversion
Acquired
Common Stock109179.00.0
2026-08-12
2026-08-14
Lin Shao-LeeS · Sale
Disposed
Common Stock5775.027.75
2026-08-12
2026-08-14
Lin Shao-LeeM · Exercise / conversion
Disposed
Common Stock
Derivative security
109179.00.0
2026-07-30
2026-08-03
Ahlers James MA · Grant / award
Acquired
Common Stock25500.00.0
2026-07-30
2026-08-03
Ahlers James MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
51000.00.0
2026-07-13
2026-07-15
Borie Dominique ChristianA · Grant / award
Acquired
Common Stock31500.00.0
2026-07-13
2026-07-15
Borie Dominique ChristianA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
63000.00.0
2026-07-09
2026-07-10
Meluzio Michael VincentA · Grant / award
Acquired
Common Stock40942.00.0
2026-07-09
2026-07-10
Meluzio Michael VincentA · Grant / award
Acquired
Common Stock
Derivative security
40942.00.0
2026-07-09
2026-07-10
Meehan Viola MongA · Grant / award
Acquired
Common Stock21800.00.0
2026-07-09
2026-08-28 · Amendment
Sarraf PashaA · Grant / award
Acquired
Common Stock18400.00.0
2026-07-09
2026-07-10
Sarraf PashaA · Grant / award
Acquired
Common Stock21800.00.0
2026-07-09
2026-08-28 · Amendment
Garzone PamelaA · Grant / award
Acquired
Common Stock18900.00.0
2026-07-09
2026-07-10
Garzone PamelaA · Grant / award
Acquired
Common Stock21800.00.0
2026-07-09
2026-07-10
Camardo Daniel A.A · Grant / award
Acquired
Common Stock21800.00.0
2026-07-09
2026-07-10
Lin Shao-LeeA · Grant / award
Acquired
Common Stock327537.00.0
2026-07-09
2026-07-10
Lin Shao-LeeA · Grant / award
Acquired
Common Stock
Derivative security
327537.00.0
2026-07-09
2026-07-10
Ray SumitaA · Grant / award
Acquired
Common Stock54589.00.0
2026-07-09
2026-07-10
Ray SumitaA · Grant / award
Acquired
Common Stock
Derivative security
54589.00.0
2026-06-01
2026-07-30 · Amendment
Lin Shao-LeeA · Grant / award
Acquired
Pre-Funded Warrants (Right to Buy)
Derivative security
90906.011.0
2026-06-01
2026-07-30 · Amendment
Lin Shao-LeeA · Grant / award
Acquired
Common Stock Warrants (Right to Buy)
Derivative security
45453.0n/a

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001645460Cue Biopharma, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Imagen Biopharma, Inc. · former SEC name · 2015-06-19 to 2015-06-19

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$9.29M$9.98M
2023-12-31$5.49M$6.07M
2022-12-31$1.25M$1.43M
2021-12-31$14.94M$18.58M
2020-12-31$3.15M$4.11M
2019-12-31$3.46M$4.56M
2018-12-31$1.14M$1.53M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗